NCT03997370 2026-03-27
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
NRG Oncology
Phase 1 Active not recruiting
Clinical Trials
11 trialsNCT06820320 2026-03-06
Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Completed
NCT04504331 2026-02-12
Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer
Stanford University
Phase 1 Terminated
NCT04126824 2025-12-17
Effect of Addition of Steroids on Duration of Analgesia
University of California, Los Angeles
Phase EARLY_PHASE1 Active not recruiting
NCT05754749 2025-09-25
Comparison of CE-DBT and MRI in Patients With Known Breast Lesions
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT04582500 2025-04-04
Virtual Colonoscopy Using Omnipaque as a Contrast Agent
Montefiore Medical Center
Completed
NCT04199754 2024-05-31
IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy
Columbia University
Phase EARLY_PHASE1 Terminated
NCT01188486 2018-04-17
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
Stanford University
Phase NA Terminated
NCT01326364 2016-07-01
Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection
Stanford University
Terminated
NCT00576563 2016-04-21
Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer
Maastricht Radiation Oncology
Phase NA Completed
NCT01200303 2015-08-05
ncCTC
Massachusetts General Hospital
Phase 2/3 Completed